Sharrp Ventures leads 100 CR investment in Naturis Cosmetics’ first institutional funding round

▴ Rahul Tandon, CEO of Naturis Cosmetics
The new influx of capital will enable manufacturing expansion and R&D capabilities.

India-wide release, 16 July 2026: India’s leading CDMO player in the fast-growing beauty & personal care (BPC) sector, Naturis Cosmetics, has raised INR 100 crore in its first external funding round. The investment was led by Sharrp Ventures, with participation from Mirabilis Investment Trust (Infosys Co-founder K. Dinesh Family Office), financial growth equity investors Anicut Capital and Niveshaay, D2C ecosystem leaders including Suyash Saraf (Hyperscale Ventures) and Yogesh Kabra, along with several prominent angel investors from pharma and specialty chemical ecosystems. 

Naturis Cosmetics is an R&D-led manufacturing company with a track record of enabling 50+ category-winning D2C and leading BPC brands in India, including Pilgrim, Purplle, Nykaa, Asaya, Hoop, Colorbar, Innovist’s Bare Anatomy, Kay Beauty, and Antinorm, amongst others. The Mumbai-based company also partners with several pharmaceutical companies like Glenmark and Dr. Reddy’s Laboratories for new-age OTC and cosmeceuticals backed by unique technologies. 

The fresh capital will enable Naturis Cosmetics to accelerate its vision of leading the next decade of innovation and growth in the BPC sector. It aims to become the platform of choice for beauty, personal care, and wellness brands across D2C, FMCG, and OTC pharma. The company also plans to expand its geographical presence across the country by establishing a new state-of-the-art production unit in Vapi, spanning 225,000 sq. ft, an experience centre in the NCR region, and a new R&D centre in Mumbai. Additionally, it will significantly scale its team across verticals. 

Over the next five years, Naturis intends to diversify into high-growth categories, including men’s grooming, body care, colour cosmetics, fragrances, and exports, while strengthening its capabilities in OTC pharma. The company also plans to deepen its innovation funnels with both existing and new brands. 

Commenting on the funds raised, Rahul Tandon, Co-Founder & CEO of Naturis Cosmetics, said, “Our long-term vision is to build India’s leading ODM platform in the BPC space. This investment is not just a vote of confidence in Naturis, but also in India’s manufacturing and innovation ecosystem. With the strategic expertise of our investors and partners, we are well-positioned to accelerate our growth, strengthen our R&D capabilities, expand our manufacturing footprint, and help build the next generation of brands from India. We are grateful for the trust our investors have placed in us and remain committed to building the backbone of the industry through innovation, agility, and integrity.”

Divya Gupta, Principal at Sharrp Ventures, added, “What stood out to us about Naturis was its ability to combine deep formulation and product development capability with strong quality systems and a customer-first way of working. Its customers see Naturis not just as a supplier, but as a partner of choice, which has enabled the company to scale rapidly while delivering strong financial performance. As Naturis grows, we believe it has the potential to become a trusted product innovation and manufacturing platform for domestic and global brands. We are happy to partner with the team in its journey of building an enduring institution.”

Furthermore, Mr. Sagar Kandhari, Partner at Ambassador Capital Partners, advised Naturis Cosmetics through its fundraising process and has joined the company’s Board to support its next phase of strategic growth and scale-up.

India’s beauty and personal care industry is entering a period of unprecedented growth. As per a recent Redseer Report, the country will be the fourth-largest beauty and personal care (BPC) market globally, growing to $40 billion by 2030. This is driven by rising consumer awareness, higher disposable incomes, and easy accessibility. Consequently, the demand for innovation-led manufacturing partners is also growing significantly. 

A profitable company with a revenue growth of 50%+ CAGR over the last four years, Naturis Cosmetics is well-positioned to lead this next phase of growth. The move marks a significant milestone not just for the company, but for India’s rapidly evolving beauty and personal care manufacturing ecosystem. Bringing together institutional investors, family offices, and experienced operators from the D2C and healthcare sectors, this first-of-its-kind investment reflects growing confidence in the manufacturing infrastructure, building a robust backbone of India’s BPC sector.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Fortis Escorts Faridabad Launches Faridabad’s First Comprehensive Lung Failure Clinic for Advanced Respiratory and Transplant CareJuly 17, 2026
What Seemed Like Persistent Gas Turned Out To Be A 30-cm Rare Cancer Occupying Most Of Her AbdomenJuly 17, 2026
Kidney Stone Prevention Initiative Unites More Than 8,200 Doctors Across India, Earns Asia Book of Records RecognitionJuly 17, 2026
Moscow radiologists introduce AI tool for hip dysplasia diagnosisJuly 17, 2026
Sharrp Ventures leads 100 CR investment in Naturis Cosmetics’ first institutional funding roundJuly 17, 2026
Eugenix Challenges Hair Loss Stigma With Nationwide 'I Chose Transformation' Campaign Featuring Boney KapoorJuly 17, 2026
How Artificial Intelligence is Reshaping Preventive Healthcare Through Earlier Detection and Smarter Clinical InsightsJuly 17, 2026
Five Common Myths About Children's Urinary Problems That Parents Should Stop BelievingJuly 17, 2026
Robotics in Surgery: How Robot-Assisted Procedures Are Transforming Healthcare in IndiaJuly 17, 2026
Wearable Health Devices: How Smart Technology Is Changing Healthcare in IndiaJuly 17, 2026
Sankara Eye Hospitals Successfully Hosts 20th Annual VISION 2020 India Conference, Celebrating 50 Years of the Sankara MovementJuly 16, 2026
Manipal Hospital Bhubaneswar Successfully Treats Rare Brain Injury Caused by Post-Traumatic Workplace AccidentJuly 16, 2026
Immuneel Therapeutics and Tata Memorial Centre Sign Strategic MoU to Advance Cell and Gene Therapy Research in India July 16, 2026
Breast Cancer Early Warning Signs: What Every Woman in India Needs to KnowJuly 16, 2026
HbA1c Test Explained: What It Measures, Normal Range, and Why It Matters for IndiansJuly 16, 2026
Not Just Weight Loss: How Bariatric Surgery Improves Diabetes, PCOS, and Thyroid-Related Health ChallengesJuly 15, 2026
Leiutis Pharmaceuticals announces CDSCO approval for Global-First Synthetic CBD Therapy for Mild to Moderate Anxiety DisordersJuly 15, 2026
Dr Agarwals Institute of Optometry and SASTRA University Jointly Launch Optometry ProgrammeJuly 15, 2026
SIMS Hospital Treats Spinal Compression in 84-Year-Old with Pacemaker Through Single-Incision Endoscopic SurgeryJuly 15, 2026
Apollo Hospitals Secunderabad Successfully Treats Achalasia Cardia Patients with Advanced POEM ProcedureJuly 15, 2026